Amyloid-beta (Aβ) retention and APOE ε4 genotype, which are representative factors affecting the progression and prognosis of AD, have been reported to affect the neuronal activity and cognitive decline significantly [24,25,26,27]. The gene discussed is APOE; the disease is Alzheimer disease.